DWTX

DOGWOOD THERAPEUTICS, INC.

DWTX · CIK 1818844 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20212024
Net Income−$12M
20212024
Operating CF−$9M
20212024
Free Cash Flow
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue————
Cost of Revenue————
Gross Profit————
R&D Expense$0.0B$0.0B$0.0B$0.0B
SG&A Expense————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-12.52$-0.28$-1.11$-1.92
EPS (Diluted)$-12.52$-0.28$-1.11$-1.92

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.1B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$-0.0B$0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B———
Capital Expenditures————
Financing Cash Flow$0.0B$0.0B$0.0B$-0.0B
← Companies